{"disease":{"id":"overactive-detrusor","name":"overactive detrusor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04693897","title":"Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT03755089","title":"Oral vs Intravesical Analgesia for Office Bladder Botox Injections","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"Women and Infants Hospital of Rhode Island","has_results":false},{"nct_id":"NCT05572918","title":"Developing a Simple Test to Diagnose Overactive Bladder","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Teesside University","has_results":false},{"nct_id":"NCT04270526","title":"Minimizing Pain During Office Intradetrussor Botox Injection","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Boston Urogynecology Associates","has_results":true},{"nct_id":"NCT03727711","title":"TPTNS: Home vs Hospital Treatment for Overactive Bladder","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"NHS Greater Glasgow and Clyde","has_results":false},{"nct_id":"NCT06059066","title":"Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction","phase":"NA","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"The Methodist Hospital Research Institute","has_results":true},{"nct_id":"NCT04197466","title":"Comparison of Different Treatments for Overactive Bladder Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Ankara Yildirim Beyazıt University","has_results":false},{"nct_id":"NCT03388086","title":"Efficacy of Two Onabotulinum Toxin Doses","phase":"","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Swiss Paraplegic Research, Nottwil","has_results":false},{"nct_id":"NCT01192568","title":"Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT07184307","title":"Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT05895045","title":"Yoga for Treatment of Overactive Bladder in Pediatric Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03451175","title":"Reproductibility of Cystometry in Multiple Sclerosis Patient","phase":"","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Pierre and Marie Curie University","has_results":false},{"nct_id":"NCT05977634","title":"Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":26,"lead_sponsor_name":"Ege University","has_results":false},{"nct_id":"NCT03080389","title":"Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections","phase":"","overall_status":"TERMINATED","enrollment_count":16,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT01539707","title":"Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT02526979","title":"A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}